Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypofractionated radiotherapy for sarcomas.

M A Ashby, C T Ago, C L Harmer

    International Journal of Radiation Oncology, Biology, Physics
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    War and Peace: What Can Bioethics Offer to Bring an End to Conflicts?

    Journal of bioethical inquiry·2024
    Same author

    Aggressive fibromatosis: evidence for a stable phase.

    Sarcoma·2008
    Same author

    Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience.

    The British journal of radiology·2005
    Same author

    One stage treatment of parathyroid cancer.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2005
    Same author

    Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey.

    Palliative medicine·2004
    Same author

    Palliative venting gastrostomy in malignant intestinal obstruction.

    Palliative medicine·2002

    High-dose weekly radiation fractions for sarcoma treatment showed low response rates and significant late normal tissue damage. This approach did not demonstrate improved therapeutic gain compared to conventional fractionation.

    Area of Science:

    • Radiation Oncology
    • Medical Physics
    • Surgical Oncology

    Background:

    • Sarcomas require effective local control strategies in radiation therapy.
    • Conventional fractionation may not always achieve optimal outcomes.
    • Investigating alternative fractionation schedules is crucial for improving treatment efficacy.

    Purpose of the Study:

    • To evaluate the efficacy and toxicity of high-dose weekly radiation fractions for sarcoma treatment.
    • To compare treatment outcomes between patients with measurable disease and postoperative patients.
    • To assess the therapeutic gain of this accelerated fractionation regimen.

    Main Methods:

    • 64 patients with sarcomas were treated with up to 7 weekly fractions of 6.6 Gy.
    • Patients were divided into two groups: Group A (measurable disease) and Group B (postoperative).

    Related Experiment Videos

  • Response rates, local recurrence, and normal tissue damage (early and late) were documented.

    • Main Results:

    • Group A showed a partial response rate of 22% with no complete responses.
    • Two out of 27 postoperative patients (Group B) experienced local relapse.
    • 26% experienced early radiation damage, and 72% of evaluable patients had late normal tissue damage, with serious morbidity in 6.
    • Therapeutic gain was not apparent with this fractionation schedule.

    Conclusions:

    • High-dose weekly radiation fractions for sarcoma treatment yielded low response rates in measurable disease.
    • The local recurrence rate in postoperative patients was comparable to conventional fractionation.
    • Significant late normal tissue damage suggests this regimen may not offer an improved therapeutic ratio.